Explore

Program Map

Start with a treatment, device, company, diagnosis, or trial ID. Each record keeps the source trail close to the claim.

161Main(26 active)

148Status checked

135Strong

320Backlog

More filters and sort (1 active)

Company-led only

5 records in Main database · 2 strong · 4 status checked

Compare	Program	Company / Sponsor	Type	Product	Modality	Stage	Status	Reliability	Evidence	Conf.	Population	Indications
Add	SPI-1005 by Sound Pharmaceuticals	Sound Pharmaceuticals	Therapeutic	-	Small Molecule	Phase 3	Active	Details checkedStrong evidence	trial · Priority 1	90%	AdultNoise-Induced+2	Hearing LossSensorineural Hearing Loss+3
Add	AOK-1	Boehringer Ingelheim	Therapeutic	-	Regenerative Medicine	Preclinical	Active	Details checkedStrong evidence	company · Priority 2	82%	AdultAge-Related+1	Hearing LossSensorineural Hearing Loss+2
Add	FX-322 by Frequency Therapeutics	Frequency Therapeutics	Therapeutic	-	Regenerative Medicine	Phase 2	Discontinued	Details checkedStatus confirmedHistorical/discontinued	company · Priority 1	96%	Adult	Hearing LossSensorineural Hearing Loss+2
Add	NHPN-1010	Otologic Pharmaceutics	Therapeutic	-	Small Molecule	Phase 1	Completed	Details checkedStatus confirmedHistorical/discontinued	company · Priority 2	89%	AdultNoise-Induced+1	Hearing LossSensorineural Hearing Loss+2
Add	WHO hearWHO Hearing Screener	World Health OrganizationSponsor	Diagnostic	Diagnostics	Diagnostic	Marketed	Active	Details checkedClinical trial listing only	publication · Priority 2	88%	AdultScreening+2	Hearing LossNoise-Induced Hearing Loss+1